mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model.

MLA

Sittplangkoon, Chutamath, et al. “MRNA Vaccine with Unmodified Uridine Induces Robust Type I Interferon-Dependent Anti-Tumor Immunity in a Melanoma Model.” Frontiers in Immunology, vol. 13, Oct. 2022, p. 983000. EBSCOhost, https://doi.org/10.3389/fimmu.2022.983000.

APA

Sittplangkoon, C., Alameh, M.-G., Weissman, D., Lin, P. J. C., Tam, Y. K., Prompetchara, E., & Palaga, T. (2022). mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model. Frontiers in Immunology, 13, 983000. https://doi.org/10.3389/fimmu.2022.983000

Chicago

Sittplangkoon, Chutamath, Mohamad-Gabriel Alameh, Drew Weissman, Paulo J C Lin, Ying K Tam, Eakachai Prompetchara, and Tanapat Palaga. 2022. “MRNA Vaccine with Unmodified Uridine Induces Robust Type I Interferon-Dependent Anti-Tumor Immunity in a Melanoma Model.” Frontiers in Immunology 13 (October): 983000. doi:10.3389/fimmu.2022.983000.